000			02270 a2200661 4500
005			20250517161656.0
264		0	_c20180605
008			201806s 0 0 eng d
022			_a1600-0641
024	7		_a10.1016/j.jhep.2017.06.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aPoordad, Fred
245	0	0	_aSafety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis. _h[electronic resource]
260			_bJournal of hepatology _c10 2017
300			_a700-707 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_a2-Naphthylamine
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnilides _xadministration & dosage
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aCarbamates _xadministration & dosage
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aCyclopropanes
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xetiology
650	0	4	_aFemale
650	0	4	_aHepatitis C, Chronic _xcomplications
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic
650	0	4	_aLiver Cirrhosis _xdrug therapy
650	0	4	_aMacrocyclic Compounds _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProline _xanalogs & derivatives
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aRitonavir _xadministration & dosage
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aSustained Virologic Response
650	0	4	_aUracil _xadministration & dosage
650	0	4	_aValine
650	0	4	_aYoung Adult
700	1		_aNelson, David R
700	1		_aFeld, Jordan J
700	1		_aFried, Michael W
700	1		_aWedemeyer, Heiner
700	1		_aLarsen, Lois
700	1		_aCohen, Daniel E
700	1		_aCohen, Eric
700	1		_aMobashery, Niloufar
700	1		_aTatsch, Fernando
700	1		_aFoster, Graham R
773	0		_tJournal of hepatology _gvol. 67 _gno. 4 _gp. 700-707
856	4	0	_uhttps://doi.org/10.1016/j.jhep.2017.06.011 _zAvailable from publisher's website
999			_c27307763 _d27307763